Sakar Healthcare Limited (NSE:SAKAR)

Market Cap	8.64B
Revenue (ttm)	2.04B
Net Income (ttm)	195.05M
Shares Out	22.25M
EPS (ttm)	8.84
PE Ratio	43.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,661
Average Volume	28,232
Open	408.05
Previous Close	408.60
Day's Range	381.00 - 411.65
52-Week Range	210.10 - 444.30
Beta	0.03
RSI	44.19
Earnings Date	Feb 5, 2026

About Sakar Healthcare

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaestheti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 342
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAKAR

Financial Performance

In 2024, Sakar Healthcare's revenue was 1.78 billion, an increase of 15.53% compared to the previous year's 1.54 billion. Earnings were 175.02 million, an increase of 49.96%.